혹시 pulse on(으)로 찾으셨나요?
뉴스
- Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the dai
- Diagnostics Rally Despite Kolon TissueGene Trial Shock[K-Bio Pulse] Investor sentiment across South Korea’s pharmaceutical and life sciences sectors remained weak on July 22 following the Phase 3 setback for Kolon TissueGene’s osteoarthritis candidate TG-...